Dr. Parveen Kumar

Dr. Parveen Kumar
Pediatrician & Neonatologist, Chandigarh

MBBS, MD, DM

  • 1 Hospital
  • Additional Professor from PGIMER, Chandigarh (1.7.2004 - Present)
  • Fellowship in Neonatal-Perinatal Medicine from oothills Hospital,University of Calgary,Alberta, Canada (8.5.2000 - 5.5.2002)
  • Associate Professor from PGIMER, Chandigarh (1.7.1999 - 30.6.2004)
  • Assistant Professor from (9.8.1994 - 30.6.1999)
  • Senior Resident( Neonatology) (8.7. 1991 - 8.8.1994)
  • Senior Resident(Pediatrics) from AIIMS, New Delhi (1.8.1990 - 30.6.1991)
  • Junior resident(Pediatrics) (1.7.1987 - 30.6.1990)
  • Junior Resident(Clinical Pathology) (1.1.1987 - 30.6.1987)
  • Internee (1.1.1986 - 31.12.1986)

Specialities

  • Pediatrics & Neonatology

Expertise

Education

  • DM ( Neonatology ) from PGIMER, Chandigarh, 1993   
  • Diplomate National Board( Pediatrics) from National Board of Exams., New Delhi, 1992
  • MD (Pediatrics) from AIIMS, New Delhi, 1990
  • MBBS from AIIMS, New Delhi, 1985

Practice Information

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Parveen Kumar and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Neonatal hyperbilirubinemia
  • Reported a large no. of babies with kernicterus which seems to occur peculiarly in North India. Presented data to show that the risk of kernicterus in in outborn babies is significantly high at bilirubin > 20 mg/dl even in absence of hemolysis. .Also showed that SGA babies are at a much greater risk for kernicterus. It was also shown that urinary iodine excretion was significantly lower in babies with higher levels of bilirubin or persistently elevated bilirubin suggesting relationship be
  • Phenobarbitone was shown to be a cheap and effective modality for managing jaundice in babies < 1500 gms in a randomized controlled trial . .In another trial, it was demonstrated that majority of neonates reporting with high bilirubin had increased serum osmolality and intravenous fluid supplementation could reduce the need for exchange transfusion in these babies
  • It was shown that donor blood G6PD deficiency can prolong the need for phototherapy and increase the need for repeat exchange transfusions –hence it is recommended to screen the donor blood for G6 PD deficiency in neonates undergoing exchange transfusion
  • Neonatal infectionsEvaluated the role of routine lumbar puncture in neonatal sepsis and showed that the yield was virtually zero in absence of symptoms. Subsequently the practice was changed to doing lumbar puncture only in presence of symptoms
  • Demonstrated the significant role of fungi in neonatal infections beyond 7 days of life even in India. Efficacy of Fluconazole as a first line therapy and its effectiveness as a prophylactic agent in decreasing fungal infections was shown
  • AsphyxiaDemonstrated that the use of NaHCO3 in neonatal resuscitation did not improve any of the outcomes. Subsequently the practice of using NaHCO3 in labor room was discontinued
  • Prophylactic phenobarbitone was evaluated in a RCT for perinatal asphyxia. It decreased the incidence of seizures and free radical production but did not improve the outcomes
  • Respiratory DistressUse of surfactant replacement therapy ( SRT) was shown to be effective for the first time in India in a large no. of babies.
  • Chronic Lung Disease was reported as an emerging problem for the first time from India
  • National Talent Search Scholarship from 1979 to 1990 awarded by National Council of Educational Research and Training ( NCERT)
  • National Neonatology Forum Gold Medal 1997 for best research paper “ Hypoglycemia in SGA babies” , December 1997, Bhilai
  • Young Investigator Award. XXII International Congress of Pediatrics, Aug 1998, Amsterdam, Netherlands
  • Alberta Children’s Hospital Foundation Research Fellowship-2001-2002 University of Calgary, Calgary, Alberta, Canada. Canadian $ 50,000/-
  • Punjab State Independence Day Award for the year 2004
  • National Neonatology Forum -Best Poster Paper Award –“ PGINeoLITE: An indigenous transilluminator” in the XXIV Annual Convention of NNF , October,2004 , Chandigarh
  • Institute Major Amir Chand Gold Medal For Best Research work in a clinical discipline presented at the 27th Annual Convocation of PGIMER, 2006 (Authors: Mehta S, Kumar P, Narang A)
  • Undertook the development of protocol manual ( Black Book) of the unit
  • Undertook the computerization – program designing and implementation of day to day patient data management in the unit
  • Joint Organizing Secretary cum Treasurer for Neonatology Update- CME cum Workshop 16-17 September,1995 Chandigarh attended by 125 delegates
  • Joint Organizing Secretary cum Treasurer for XVI Annual Convention of National Neonatology Forum, November1-3,1996 Chandigarh attended by 700 delegates
  • Organizing Secretary for XXIV Annual Convention of National Neonatology Forum, October 28-31,2004 Chandigarh attended by 800 delegates
  • Organized the Indian part of Chandigarh-Calgary Neonatal Nursing Training program funded by Rose Foundation, Alberta, Canada
  • National Neonatology Forum ( NNF)
  • Indian Academy of Pediatrics ( IAP)
  • National Academy of Medical sciences( MNAMS)
  • National Faculty of Neonatal Resuscitation
  • Editorial Board of Journal of Neonatology ( Bulletin of National Neonatology Forum) 1995-99 , 2005-till present
  • Advisory Board of Journal of Neonatology ( Bulletin of National Neonatology Forum) 2000-04
  • Member of Publication Committee of National Neonatology Forum 1999-2003
  • Member of Equipment Committee of National Neonatology Forum 1999-2003
  • Convenor of Equipment Committee of National Neonatology Forum 2004-till date
  • Member of Board of Medical Experts for certifying Brain Stem Death at PGIMER, Chandigarh July2005
  • Invited in 2005 to review for the McMaster Online Rating of Evidence (MORE) system to help build the next generation of information resources to make it easier and fasterfor physicians to reach evidence-based clinical decisions